A randomized, placebo-controlled trial of aprotinin to reduce primary graft dysfunction following lung transplantation.
Herrington CS, Prekker ME, Arrington AK, Susanto D, Baltzell JW, Studenski LL, Radosevich DM, Kelly RF, Shumway SJ, Hertz MI, Bittner HB, Dahlberg PS.
Herrington CS, et al. Among authors: hertz mi.
Clin Transplant. 2011 Jan-Feb;25(1):90-6. doi: 10.1111/j.1399-0012.2010.01319.x. Epub 2010 Aug 19.
Clin Transplant. 2011.
PMID: 20731686
Clinical Trial.